Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: Diagnostic relevance in patients suffering from acute thrombotic microangiopathies [4]

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 4, 2007, Pages 866-867

  Meyer, S C ^a   Sulzer, I ^a   Lammle B ^a   Kremer Hovinga, Johanna A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; SODIUM HYDROXIDE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

BILIRUBIN BLOOD LEVEL; BIOASSAY; BLOOD ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; HIGH TEMPERATURE PROCEDURES; HUMAN; HYPERBILIRUBINEMIA; IMMUNOBLOTTING; LETTER; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SAMPLING; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACUTE DISEASE; ADAM PROTEINS; BILIRUBIN; CHEMISTRY, CLINICAL; HEMATOLOGIC DISEASES; HUMANS; HYPERBILIRUBINEMIA; KINETICS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REPRODUCIBILITY OF RESULTS; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 34147136218     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02438.x     Document Type: Letter

References (6)

1. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005; 129: 93-100.
2. Groot E, Hulstein JJ, Rison CN, de Groot PG, Fijnheer R. FRETS-VWF73: A rapid and predictive tool for thrombotic thrombocytopenic purpura. J Thromb Haemost 2006; 4: 698-9.
3. Kremer Hovinga JA, Mottini M, Lämmle B. Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: Comparison with other assay methods. J Thromb Haemost 2006; 4: 1146-8.
4. Mahdian R, Rayes J, Girma JP, Houllier A, Obert B, Meyer D, Veyradier A. Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples. Thromb Haemost 2006; 95: 1049-51.
5. Studt JD, Böhm M, Budde U, Girma JP, Varadi K, Lämmle B. Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: A multicenter comparison of different assay methods. J Thromb Haemost 2003; 1: 1882-7.
6. Studt JD, Kremer Hovinga JA, Antoine G, Hermann M, Rieger M, Scheiflinger F, Lämmle B. Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: In vitro inhibition of ADAMTS13 activity by hemoglobin. Blood 2005; 105: 542-4.